Development of New Approach Methodologies to Reduce Animal Use in Toxicity Testing
- ICCVAM Activities Under the U.S. Strategic Roadmap (2MB)
- FDA/CDER Considerations on NAMs for Pharmaceutical Development (540KB)
- Qualification of In Vitro Alternatives for Biocompatibility Assessment of Medical Devices: Use of Medical Device Development Tools (MDDTs) (561KB)
- U.S. Army Combat Capabilities Development Command Chemical Biological Center (2MB)
- Reduction of Testing on Vertebrates Under the Amended Toxic Substances Control Act (278KB)
- Evaluation and Implementation of New Approach Methodologies for Evaluation of Pesticide Chemicals (699KB)
- Pesticides Invention to Market (517KB)
- Two Current Gaps for Incorporation of NAMs into Toxicity Testing and Risk Assessment (2MB)
- IQ MPS Affiliate Perspective on Characteristics and Requirements for New Approach Methodologies (NAMs) (4MB)
- SBIR/STTR Town Hall Meeting (146KB)
Contacts
-
-
Daniel T. Shaughnessy, Ph.D.
Health Scientist Administrator -
Tel 984-287-3321
Fax 919-541-0146
[email protected] -
P.O. Box 12233Mail Drop K3-04Durham, NC 27709
-
-
Lingamanaidu V. Ravichandran, Ph.D.
Health Scientist Administrator -
Tel 984-287-3309
[email protected] -
P.O. Box 12233Mail Drop K3-05Durham, NC 27709